Summit Therapeutics Share Discussion Threads

[sidny1] 20/9/2018 08:33

Sorry for my naivety but when are the interim results going to be posted?

[chrisatrdg] 20/9/2018 07:31

Interesting to see NASDAQ post close went up 1.28% to $2.38 = £0.36p with a number of 1,000 Buys.NASDAQ still ahead of AIM hopefully AIM will catch up.

[algernon2] 19/9/2018 22:31

"Tomorrow's another day"

[dan1nat1] 19/9/2018 22:12

Some nice afternoon buys the last two days...let's see what tomorrow brings.

[chrisatrdg] 19/9/2018 21:08

Hi b1tcoin - I am waiting for the Thursday results at present no news on the horizon as far as I can see hoping for some good results & to see how Summit have dealt with the DMD saga.For & me & others I think nothing much to talk about all very flat.

[algernon2] 15/9/2018 12:33

I would be Chris but will be at work till late. I will catch up on the news when I get home and listen to any repeat after reading any posts on this BB.

[chrisatrdg] 15/9/2018 12:29

Hi All - Lets hope next weeks conference call on the 6 months results will generate some interesting comments from the floor hopefully better than the last one.Regards

PS I will be listening anyone else next Thursday lunchtime.

[kirk 6] 15/9/2018 11:20

Got a long way to go even to the last fib retracement level from the £2.20 drop

[waterloo01] 15/9/2018 10:21

36p and something brewing. lol I take my tea somewhat stronger than that.

[kirk 6] 15/9/2018 09:52

Yes jumped again after Nasdaq close! Why is it up so much?

[chrisatrdg] 14/9/2018 22:00

Post close now up 10.84% on Nasdaq = to £0.36 - something brewing?

[kirk 6] 14/9/2018 21:28

Closed up 7.5% on Nasdaq

[waterloo01] 14/9/2018 16:37

Seems to have woken them up a bit.

[multiplural] 14/9/2018 16:09

waterloo Thanks for these links. Indeed interesting from a Summit perspective. I can see rather large interest in the ADS at higher prices today, could come from this information. Thanks again.

[waterloo01] 14/9/2018 15:52

Antimicrobial Resistance Information from FDA

[chrisatrdg] 14/9/2018 12:54

RNS Today

Summit Therapeutics to Participate in Upcoming Investor Conferences

Summit Therapeutics plc
(‘Summit’; or the ’Company’;)

Summit Therapeutics to Participate in Upcoming Investor Conferences

Oxford, UK, and Cambridge, MA, US, 14 September 2018 – Summit Therapeutics plc (NASDAQ: SMMT, AIM: SUMM) announces that management will participate in one on one meetings for two upcoming investor conferences in New York City.

Janney Healthcare Conference: 17 September 2018

Oppenheimer Fall Summit: 26 September 2018

There will be no podium presentations at these meetings.

About Summit Therapeutics
Summit Therapeutics is a leader in antibiotic innovation. Our new mechanism antibiotics are designed to become the new standards of care for the benefit of patients, and create value for payors and healthcare providers. We are currently developing new mechanism antibiotics for C. difficile infection and gonorrhoea and are using our proprietary Discuva Platform to expand our pipeline. For more information, visit www.summitplc.com and follow us on Twitter @summitplc.

Contacts

Summit
Glyn Edwards / Richard Pye (UK office) Tel: [phone]
Erik Ostrowski / Michelle Avery (US office) [phone]

Cairn Financial Advisers LLP (Nominated Adviser) Tel: [phone]
Liam Murray / Tony Rawlinson

N+1 Singer (Joint Broker) Tel: [phone]
Aubrey Powell / Jen Boorer, Corporate Finance
Tom Salvesen, Corporate Broking

Panmure Gordon (Joint Broker) Tel: [phone]
Freddy Crossley, Corporate Finance
James Stearns, Corporate Broking

MSL Group (US) Tel: [phone]
Jon Siegal [e-mail]

Consilium Strategic Communications (UK) Tel: [phone]
Mary-Jane Elliott / Jessica Hodgson / [e-mail]
Lindsey Neville
-END-

[chrisatrdg] 14/9/2018 12:48

RNS Today

Summit Therapeutics plc
(‘Summit’; or the ’Company’;)

Summit Therapeutics to Report Financial Results for the Second Quarter and Half Year Ended 31 July 2018 on 20 September 2018

Oxford, UK, and Cambridge, MA, US, 14 September 2018 - Summit Therapeutics plc (NASDAQ: SMMT, AIM: SUMM), a leader in new mechanism antibiotic innovation, will announce its financial results for the second quarter and half year ended 31 July 2018 on 20 September 2018.
Summit will host a conference call the same day at 1:00pm BST / 8:00am EDT. Conference call information will be included in the second quarter and half year results press release, and a replay of the call will also be available through the Company’s website, www.summitplc.com.
About Summit Therapeutics
Summit Therapeutics is a leader in antibiotic innovation. Our new mechanism antibiotics are designed to become the new standards of care for the benefit of patients, and create value for payors and healthcare providers. We are currently developing new mechanism antibiotics for C. difficile infection and gonorrhoea and are using our proprietary Discuva Platform to expand our pipeline. For more information, visit www.summitplc.com and follow us on Twitter @summitplc.
Contacts
Summit
Glyn Edwards / Richard Pye (UK office) Tel: [phone]
Erik Ostrowski / Michelle Avery (US office) [phone]

Cairn Financial Advisers LLP (Nominated Adviser) Tel: [phone]
Liam Murray / Tony Rawlinson

N+1 Singer (Joint Broker) Tel: [phone]
Aubrey Powell / Jen Boorer, Corporate Finance
Tom Salvesen, Corporate Broking

Panmure Gordon (Joint Broker) Tel: [phone]
Freddy Crossley, Corporate Finance
James Stearns, Corporate Broking

MSL Group (US) Tel: [phone]
Jon Siegal [e-mail]

Consilium Strategic Communications (UK) Tel: [phone]
Mary-Jane Elliott / Jessica Hodgson / [e-mail]
Lindsey Neville
-END-

[waterloo01] 11/9/2018 18:59

It's one reason they are so keen to push the business case behind being 1st/2nd line treatment. The difference is huge in terms of revenues and sensible if you follow good stewardship. Still waiting on FDA re further 'pull' incentives.

[algernon2] 11/9/2018 18:53

Courtesy of Thoth2 on lse:

"Merck heralds a rare Big Pharma success for antibiotic PhIII, but it’s also a cautionary tale about the market.."



food for thought:maybe how others will see Summ for a while.

[the canadian mounted] 06/9/2018 20:48

Bitcoin you old side winder,welcome back!